Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aura Biosciences (AURA) Income from Continuing Operations (2020 - 2026)

Aura Biosciences filings provide 7 years of Income from Continuing Operations readings, the most recent being 33685000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations fell 22.56% to 33685000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 112386000.0 through Mar 2026, down 19.46% year-over-year, with the annual reading at 106191000.0 for FY2025, 23.05% down from the prior year.
  • Income from Continuing Operations hit 33685000.0 in Q1 2026 for Aura Biosciences, down from 25552000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 12811000.0 in Q1 2022 and bottomed at 33685000.0 in Q1 2026.
  • Average Income from Continuing Operations over 5 years is 21345588.24, with a median of 20337000.0 recorded in 2024.
  • The largest annual shift saw Income from Continuing Operations plummeted 116.15% in 2022 before it fell 1.35% in 2025.
  • Aura Biosciences' Income from Continuing Operations stood at 17613000.0 in 2022, then fell by 25.65% to 22131000.0 in 2023, then fell by 13.92% to 25212000.0 in 2024, then fell by 1.35% to 25552000.0 in 2025, then plummeted by 31.83% to 33685000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Income from Continuing Operations are 33685000.0 (Q1 2026), 25552000.0 (Q4 2025), and 26130000.0 (Q3 2025).